BioMedomics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioMedomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12131
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platform. It offers products such as alpha-thal scan, rapid diagnostic test for alpha-thalassemia; sickle scan, rapid diagnostic test for sickle cell disease and trait; and others. The company’s pipeline products are used for treating Troponin, vitamin D deficiency and testosterone deficiency. BioMedomics is headquartered in Durham, North Carolina, the US.

BioMedomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMedomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMedomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMedomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMedomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioMedomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMedomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
BioMedomics Raises USD0.5 Million in Venture Financing 10
BioMedomics Raises USD0.3 Million in Venture Financing 11
BioMedomics Raises US$0.7 Million In First Round Of Venture Financing 12
BioMedomics Inc – Key Competitors 13
BioMedomics Inc – Key Employees 14
BioMedomics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
BioMedomics Inc, Medical Equipment, Key Facts 2
BioMedomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioMedomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMedomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMedomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMedomics Inc, Deals By Market, 2012 to YTD 2018 8
BioMedomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMedomics Raises USD0.5 Million in Venture Financing 10
BioMedomics Raises USD0.3 Million in Venture Financing 11
BioMedomics Raises US$0.7 Million In First Round Of Venture Financing 12
BioMedomics Inc, Key Competitors 13
BioMedomics Inc, Key Employees 14

List of Figures
BioMedomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioMedomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioMedomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioMedomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioMedomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMedomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioMedomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMedomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioMedomics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atlantic Power Corporation (ATP):電力:M&Aディール及び事業提携情報
    Summary Atlantic Power Corporation (Atlantic Power) is an electric utility that owns and operates diversified power generation assets. It produces electricity from various sources including biomass, coal, hydro, and natural gas sources. The company sells power to utilities and other large commercial …
  • Sequella Inc-医療機器分野:企業M&A・提携分析
    Summary Sequella Inc (Sequella) is a clinical-stage pharmaceutical company that develops and commercializes small molecule and natural product-based therapeutics for the treatment of infectious diseases. The company’s product pipeline include SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid anti …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Eramet:企業の戦略・SWOT・財務情報
    Eramet - Strategy, SWOT and Corporate Finance Report Summary Eramet - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Kawasaki Kisen Kaisha Ltd (9107):石油・ガス:M&Aディール及び事業提携情報
    Summary Kawasaki Kisen Kaisha Ltd (K Line) is a global logistics company. It provides land transportation, air transportation, marine transportation, and harbor transportation. It owns and operates dry bulk carriers, LNG carriers, tankers, car carriers and containerships. The company also provides s …
  • Boehringer Ingelheim GmbH:企業の戦略的SWOT分析
    Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Okamura Corporation:企業の戦略・SWOT・財務情報
    Okamura Corporation - Strategy, SWOT and Corporate Finance Report Summary Okamura Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tate & Lyle PLC:企業のM&A・事業提携・投資動向
    Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Empire Co Ltd:戦略・SWOT・企業財務分析
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Arcus SA (ARC):企業の財務・戦略的SWOT分析
    Summary Arcus SA (Arcus) is an information technology service provider that offers integrated systems for document management and mass correspondence management. Its product includes tims controlling system, which is used for telematics operation. It provides document management products such as pri …
  • Monteloeder S.L.:企業の戦略・SWOT・財務情報
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Canadian Solar Inc (CSIQ):電力:M&Aディール及び事業提携情報
    Summary Canadian Solar Inc (Canadian Solar) is a solar power company. It designs, develops, and manufactures solar ingots, wafers, modules, cells, and other solar power products. The company’s products include a range of solar modules for use in residential, commercial and industrial solar power gen …
  • CVS Health Corporation:企業の戦略・SWOT・財務情報
    CVS Health Corporation - Strategy, SWOT and Corporate Finance Report Summary CVS Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • D.R. Horton, Inc.:企業の戦略・SWOT・財務情報
    D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆